Recolony among the Top100 Swiss Startups

Newsroom
Learn more about Recolony bacteria-based cancer therapy, plus never miss an event.



- Apr 20
- 1 min
Recolony gets featured by Handelzeitung


- Feb 23
- 1 min
Recolony receives CHF 150,000 from Venture Kick

- Feb 23
- 1 min
Recolony nominated as "Newcomer of the year"

- Dec 2, 2022
- 1 min
Recolony selected as one of the Hello Tomorrow Deep Tech Pioneers!


- Nov 29, 2022
- 1 min
Recolony gets support from InnoBooster

- Sep 15, 2022
- 1 min
SWICA interviews Recolony



- Jul 25, 2022
- 1 min
Recolony is selected for Venture Leaders Biotech


- Jul 25, 2022
- 1 min
Recolony wins Venture Kick Stage II


- May 5, 2022
- 1 min
Recolony gets the Kick!

- Apr 22, 2022
- 1 min
Our CEO is highlighted in the UZH Annual Report 2021


- Apr 14, 2022
- 1 min
We are finalists of >>venture>>, Switzerlands leading startup competition

- Apr 13, 2022
- 1 min
We are part of the Swiss Microbiomes Forum

- Apr 12, 2022
- 1 min
Pharmabiotics Conference 2022


- Mar 24, 2022
- 1 min
Recolony raises 200.000 CHF from the USZ Health Innovation Hub


- Feb 11, 2022
- 1 min
Our CEO wins a young women scientist award


- Jan 25, 2022
- 1 min
Werner Siemens Stiftung interviews Ana Montalban-Arques


- Nov 7, 2021
- 1 min
Our CEO wins the Falling Walls Breakthrough of Year in the Emerging Talents Category


- Oct 15, 2021
- 1 min
Our research gets featured in Cell Reports Medicine.


- Sep 28, 2021
- 1 min
Ana Montalban-Arques wins Falling Walls Lab Switzerland


- Dec 10, 2020
- 1 min
Ana Montalban-Arques receives support from the BRIDGE programme.

- Jun 8, 2020
- 1 min
Ana Montalban-Arques receives 150.000CHF from the UZH Entrepreneur Fellowship